{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:02:34Z","timestamp":1790074954162,"version":"4.0.1"},"reference-count":59,"publisher":"American Society for Microbiology","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP24bk0104158 and JP25bk0104193"],"award-info":[{"award-number":["JP24bk0104158 and JP25bk0104193"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Microbiol Spectr"],"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>High-throughput sequencing (HTS) is an agnostic virus detection technology that can replace or supplement the conventional adventitious virus assays used for safety testing of biologics. Transcriptomic HTS is particularly suitable for the detection of replicating viruses. We have evaluated the sensitivity of virus detection by transcriptomic HTS using targeted and non-targeted bioinformatics analysis of infected cells spiked into a background of uninfected cells, mimicking material representing a test sample from product manufacturing. Eight laboratories tested a mix of Raji cells (expressing Epstein-Barr virus [EBV] RNAs without virus production) and EBV-negative Ramos cells at ratios ranging from 0.5 to 0.00005. Seven laboratories performed the analysis using different HTS protocols, while the eighth laboratory quantified EBV RNA recovery in all extracted samples by quantifying EBNA-1 by RT-ddPCR assay. All participants detected EBV transcripts at a 0.001 ratio with the targeted analysis and a 0.01 ratio with the non-targeted analysis (i.e., one infected cell in 100 uninfected cells), with four laboratories achieving detection at the 0.0001 ratio for both analysis. The results of the spiking studies demonstrated the capabilities of transcriptomic HTS for adventitious virus detection in cell lines used for the production of biologics, and highlight that optimization in the workflow can improve HTS virus detection.<\/jats:p>\n                    <jats:sec>\n                      <jats:title>IMPORTANCE<\/jats:title>\n                      <jats:p>High-throughput sequencing (HTS) is currently recognized as a powerful technology for broad virus detection. While HTS can be considered an alternative method to replace or supplement the conventional adventitious virus detection assays for testing biologics, its routine implementation has been challenging due to the complexities of the HTS workflow, including the matrix of the test sample, selection of HTS methodology (viromic, genomic, or transcriptomic), and variability in the protocols (from sample preparation to bioinformatic analysis). The study demonstrated the performance and capabilities of the transcriptomic HTS approach for the detection of virus-infected cells using different workflows presented by seven laboratories. The study indicated that regardless of the protocol used, all participants detected viral RNA at the 0.01 ratio; however, certain HTS protocols demonstrated better sensitivity of viral detection.<\/jats:p>\n                    <\/jats:sec>\n                  <\/jats:sec>","DOI":"10.1128\/spectrum.00066-26","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:00:18Z","timestamp":1790071218000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":0,"title":["A collaborative study evaluating the detection of virus-infected cells by transcriptomic high-throughput sequencing"],"prefix":"10.1128","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7980-1342","authenticated-orcid":false,"given":"No\u00e9mie","family":"Deneyer","sequence":"first","affiliation":[{"name":"GSK","place":["Wavre, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8892-7465","authenticated-orcid":false,"given":"Pei-Ju","family":"Chin","sequence":"additional","affiliation":[{"name":"Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Review, U.S. Food and Drug Administration","place":["Silver Spring, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1486-7647","authenticated-orcid":true,"given":"Guillaume","family":"Bayon-Vicente","sequence":"additional","affiliation":[{"name":"GSK","place":["Rixensart, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Beurdeley","sequence":"additional","affiliation":[{"name":"PathoQuest","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan H.","family":"Cleveland","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05xpvk416","id-type":"ROR","asserted-by":"publisher"}],"name":"Biomolecular Measurement Division, National Institute of Standards and Technology","place":["Gaithersburg, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Colinet","sequence":"additional","affiliation":[{"name":"GSK","place":["Rixensart, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Cruveiller","sequence":"additional","affiliation":[{"name":"PathoQuest","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Eloit","sequence":"additional","affiliation":[{"name":"PathoQuest","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanaz","family":"Gilchrist","sequence":"additional","affiliation":[{"name":"Sanofi","place":["Toronto, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Hashiba","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03tgsfw79","id-type":"ROR","asserted-by":"publisher"}],"name":"Graduate School of Science, Technology, and Innovation, Kobe University","place":["Kobe, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7727-2018","authenticated-orcid":false,"given":"Christophe","family":"Lambert","sequence":"additional","affiliation":[{"name":"GSK","place":["Rixensart, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Lembo","sequence":"additional","affiliation":[{"name":"EMD Serono RBM S.p.A. Istituto di Ricerche Biomediche A. Marxer","place":["Colleretto Giacosa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka-Wai","family":"Leong","sequence":"additional","affiliation":[{"name":"Analytical Research and Development, Microbiology Strategy and Testing Department, Biotherapeutics Pharm. Sci., Pfizer Inc.","place":["Andover, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandye","family":"Micheals","sequence":"additional","affiliation":[{"name":"Analytical Research and Development, Microbiology Strategy and Testing Department, Biotherapeutics Pharm. Sci., Pfizer Inc.","place":["Andover, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Moreira","sequence":"additional","affiliation":[{"name":"PathoQuest","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiko","family":"Nakashima","sequence":"additional","affiliation":[{"name":"Machine Learning and Computational Sciences, Discovery & Early Development Department, Medicine Design, Pfizer Inc.","place":["Cambridge, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Olgiati","sequence":"additional","affiliation":[{"name":"EMD Serono RBM S.p.A. Istituto di Ricerche Biomediche A. Marxer","place":["Colleretto Giacosa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasrin","family":"Salehi","sequence":"additional","affiliation":[{"name":"Analytical Research and Development, Microbiology Strategy and Testing Department, Biotherapeutics Pharm. Sci., Pfizer Inc.","place":["Andover, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinyu","family":"Sun","sequence":"additional","affiliation":[{"name":"Machine Learning and Computational Sciences, Discovery & Early Development Department, Medicine Design, Pfizer Inc.","place":["Cambridge, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhisa","family":"Uchida","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03tgsfw79","id-type":"ROR","asserted-by":"publisher"}],"name":"Graduate School of Science, Technology, and Innovation, Kobe University","place":["Kobe, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Vandeputte","sequence":"additional","affiliation":[{"name":"GSK","place":["Rixensart, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhe","family":"Yuan","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03tgsfw79","id-type":"ROR","asserted-by":"publisher"}],"name":"Graduate School of Science, Technology, and Innovation, Kobe University","place":["Kobe, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Yusa","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03tgsfw79","id-type":"ROR","asserted-by":"publisher"}],"name":"Graduate School of Science, Technology, and Innovation, Kobe University","place":["Kobe, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria Maria","family":"Zanda","sequence":"additional","affiliation":[{"name":"EMD Serono RBM S.p.A. Istituto di Ricerche Biomediche A. Marxer","place":["Colleretto Giacosa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5633-6131","authenticated-orcid":true,"given":"Arifa S.","family":"Khan","sequence":"additional","affiliation":[{"name":"Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Review, U.S. Food and Drug Administration","place":["Silver Spring, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"e_1_3_4_2_2","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). 2023. Viral safety evaluation of biotechnology products derived from cell lines of human or animal origin Q5A(R2)."},{"key":"e_1_3_4_3_2","unstructured":"European Pharmacopoeia. 2008. 2.6.16. Tests for extraneous agents in viral vaccines for human use. European Directorate for the Quality of Medicines and HealthCare."},{"key":"e_1_3_4_4_2","unstructured":"European Pharmacopoeia. 2005. Chapter 5.2.3. Cell substrates for the production of vaccines for human use. European Directorate for the Quality of Medicines and HealthCare."},{"key":"e_1_3_4_5_2","unstructured":"US Food and Drug Administration. 2010. Guidance for industry: characterization and qualification of cell substrates and other biological materials used in the production of viral vaccines for infectious disease indications."},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-020-0507-2"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2022.10.002"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2014.07.003"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02690-09"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00780-14"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00307-17"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.5731\/pdajpst.2016.007161"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.3390\/v10100566"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.12.020"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2022.11.003"},{"key":"e_1_3_4_16_2","unstructured":"European Pharmacopoeia. 2017. 5.2.14. Substitution of in vivo methods by in vitro methods for the quality control of vaccines. European Directorate for the Quality of Medicines and HealthCare."},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-025-01104-1"},{"key":"e_1_3_4_18_2","unstructured":"European Pharmacopoeia. 2024. 2.6.41. High-throughput sequencing for the detection of viral extraneous agents."},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-020-0207-4"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2023.07.019"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-025-01351-2"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2019.03.008"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/jb.91.3.1248-1256.1966"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1159\/000149930"},{"key":"e_1_3_4_25_2","unstructured":"Bushnell. 2015. BBMap\/BBTools. https:\/\/sourceforge.net\/projects\/bbmap\/."},{"key":"e_1_3_4_26_2","unstructured":"Andrews S. 2010. FastQC: a quality control tool for high throughput sequence data. http:\/\/www.bioinformatics.babraham.ac.uk\/projects\/fastqc."},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.3317"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btp352"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btl158"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2836(05)80360-2"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/msphere.00286-25"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/mSphereDirect.00069-18"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-10-421"},{"key":"e_1_3_4_34_2","unstructured":"Illumina Inc. 2020. Bcl2fastq conversion software (Version 2.20). https:\/\/rrid.site\/data\/source\/nlx_144509-1\/search?q=bcl2fastq2&amp;l=bcl2fastq2."},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btu170"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btp324"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/gigascience\/giab008"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.3390\/v10100528"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046450"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bty560"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.1923"},{"key":"e_1_3_4_42_2","unstructured":"Pertea G. 2015. Fqtrim: v0.97. doi:10.5281\/zenodo.593893"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btq033"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","unstructured":"Li H. 2013. Aligning sequence reads clone sequences and assembly contigs with BWA-MEM. arXiv. doi:10.48550\/arXiv.1303.3997","DOI":"10.48550\/arXiv.1303.3997"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0163962"},{"key":"e_1_3_4_46_2","unstructured":"Rice P Bleasby A Ison J. 2009. The EMBOSS users guide. http:\/\/emboss.open-bio.org\/html\/use\/index.html."},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-019-2996-x"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btv033"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bts635"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1089\/cmb.2006.13.1028"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkt389"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.5731\/pdajpst.2014.01023"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/0888-7543(88)90007-9"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(89)90394-2"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2012.06.008"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00226-19"},{"key":"e_1_3_4_57_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01593-18"},{"key":"e_1_3_4_58_2","doi-asserted-by":"publisher","DOI":"10.3390\/v13112122"},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-018-4703-0"},{"key":"e_1_3_4_60_2","unstructured":"Illumina. 2017. Effects of index misassignment on multiplexing and downstream analysis. https:\/\/www.illumina.com\/content\/dam\/illumina-marketing\/documents\/products\/whitepapers\/index-hopping-white-paper-770-2017-004.pdf?linkId=36607862."}],"container-title":["Microbiology Spectrum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.00066-26","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.00066-26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:00:29Z","timestamp":1790071229000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/spectrum.00066-26"}},"subtitle":[],"editor":[{"given":"J. J.","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":59,"alternative-id":["10.1128\/spectrum.00066-26"],"URL":"https:\/\/doi.org\/10.1128\/spectrum.00066-26","relation":{},"ISSN":["2165-0497"],"issn-type":[{"value":"2165-0497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"assertion":[{"value":"2026-01-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00066-26"}}